Navigation Links
Health costs soar as 60 million Americans classed as obese

A new method for manipulating macromolecules has been developed by researchers at the University of Illinois at Urbana-Champaign. The technique uses double-stranded DNA to direct the behavior of other molecules.

In previous DNA nanotechnology efforts, duplex DNA has been used as a static lattice to construct geometrical objects in three dimensions. Instead of manipulating DNA alone into such shapes, the researchers are using DNA to control the folding and resulting structure of RNA. Eventually, they envision building supramolecular machines whose inner workings are governed by twisted strands of DNA.

In a paper that has been accepted for publication in the Journal of the American Chemical Society, and posted on its Web site, Silverman and graduate student Chandrasekhar Miduturu begin with a piece of unfolded RNA. Through specific chemical reactions, they attach two strands of DNA, each resembling one side of a ladder. The two DNA strands spontaneously bind together, then the researchers add magnesium ions to initiate folding of the RNA.

"Folding of the RNA structure competes with formation of the DNA constraint until a chemical balance is reached," Silverman said. "In some cases, the DNA is like a barnacle, just stuck onto the RNA without perturbing its structure. In other cases, the DNA changes the RNA structure. We can predict which situation will occur based on the shape of the RNA and on the attachment points of the DNA constraint."

In cases where the normal RNA shape and the DNA constraint cannot co-exist simultaneously, the balance between competing RNA and DNA structures is controlled by the concentration of magnesium ions, Silverman said.

In work not yet published, the researchers have also shown that the effects of the DNA constraint on the RNA structure can be modulated by external stimuli such as DNA oligonucleotide strands, protein enzymes and chemical reagents.

While Silverman and Miduturu are currently usi
'"/>

Source:


Page: 1 2

Related biology news :

1. BioMed Central welcomes the new National Institutes of Health public access policy
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Going To Extremes To Improve Human Health
4. Patient-choice C-section rate rises 36%: HealthGrades study
5. Grand Challenges in Global Health initiative funds Yale project
6. Health benefits of a Christmas brandy
7. Health of coral reefs detected from orbit
8. Health of Acehnese reefs in the wake of the tsunami shows human impacts more harmful
9. Healthy coral reefs of Madagascar resisting damage from climate change
10. Health Canada approves cold and flu medicine
11. Mailman School of Public Health researchers report blood DNA can be early predictor of liver cancer

Post Your Comments:
(Date:11/4/2009)...ic corridors in the cities of Long Beach and River...of preventable childhood asthma, and the true impa...ase has likely been underestimated, according to r...a (USC). , The study, which appears in an onlin...h , estimated that nine percent of all childhood a...
(Date:11/4/2009)...ity of Oklahoma at Norman has received more than $...encies as part of the federal stimulus program, br...d by OU researchers to $23 million. Thirty-three ...ging from archaeology to weather. , "The univers...ach to matching areasof scholarly excellence to fe...
(Date:11/4/2009)..., Mass., Oct. 20 Aware, ...band technology and biometrics software, today rep...ed September 30, 2009. ,, Michael Tzannes, Aw..."Earlier today, we announced an agreement to sell ...q, a new fabless semiconductor company being spun ...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 1NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 2NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 1Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 8Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 1Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 2Consumer Reports Health 3A Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill 5853 3
...ls shiver when exposed to cold air but not when di...elieve allows the diving seal to conserve oxygen a...ng dives. , The researchers presented the study at...Comparative Physiology 2006: Integrating Diversity...rchers, Arnoldus Schytte Blix, Petter H. Kvadsheim...
...organelle called the nucleolus resides deep within...ost critical functions: it manufactures ribosomes,...nformation carried by messenger RNA into proteins ...Peng, researchers in the Life Sciences Division of...onal Laboratory, have now discovered two pathways ...
...rand new approach to treating severe nerve pain ?b...lar target ?has been discovered by University of U...-dwelling cone snails. , "We found a new way to ...ered by hundreds of millions of people on Earth," ...earch professor of biology, and research director ...
Other Biology News:Seals protect brain, conserve oxygen by turning off shivering response on icy dives 2Seals protect brain, conserve oxygen by turning off shivering response on icy dives 3Regulating the nuclear architecture of the cell 2Regulating the nuclear architecture of the cell 3Regulating the nuclear architecture of the cell 4Regulating the nuclear architecture of the cell 5A new target for painkillers 2A new target for painkillers 3A new target for painkillers 4
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/6/2009)...nda for Arrowhead’s 2010 Personalized Medici...lace on February 22-24, 2010 in Philadelphia, has ...ll highlight key issues in forming partnerships an...ces. , Minneapolis, MN (P...’s 2010 Personalized Medicine Partnerships ...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009)...RNewswire/ -- DSM Pharmaceutical Products today an...with Galenix, Saint Jean D,Illac, France, where DS...ring partner for Galenix commercial products on a ...te on business development opportunities co-market...he strength of Galenix in drug product development...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...he University of Maryland today announces nine f...K Business Plan Competition. , , Finalists presen... May 8, from 1:30 to 4:30 p.m., at the University...naged by the Maryland Technology Enterprise Instit...chnology Category include: , , , Flex...
...armaceutical company Kiadis,Pharma reported prelim...ial,in mismatched bone marrow transplantations. Da...igator Dr. Denis Claude Roy during the prestigious...e Marrow Transplantation,meeting (EBMT) in Gotebor...ighest ranked presentations, representing the most...
...pions Biotechnology, Inc. (OTC Bulletin Board: CS...ced preclinical platforms and tumor specific data ...ished a UK subsidiary, Champions Biotechnology UK ...usiness. Guy Malchi has been appointed General Ma... branch in Israel. , , "We have been experiencin...
Other Biology Technology:University of Maryland Announces Finalists for $75K Business Plan Competition 2University of Maryland Announces Finalists for $75K Business Plan Competition 3University of Maryland Announces Finalists for $75K Business Plan Competition 4University of Maryland Announces Finalists for $75K Business Plan Competition 5University of Maryland Announces Finalists for $75K Business Plan Competition 6Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations 2Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business 2Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business 3Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business 4
... Display Cloning System facilitates the display of...iophage M13 as coat protein fusions, creating a ph...its encoding DNA sequence. Peptide ligands for a v...ightforward method of biopanning. The supplied dis...
...ul cell culture or fermentation is the ability to ...nd make rapid adjustments in response to changes i...zers provide immediate analysis of key nutrients, ...ation media. BioProfile analyzers are fully automa...
...yolk protein Vtg in plasma from juvenile or male f...ine disrupting chemicals (EDCs) with estrogenic ef... accepted screening test for the estrogenic effect... is a double-antibody immunometric (sandwich) EIA ...
...s over 23 years of experience in the development o...o large and small peptides, proteins, haptens, car...mid DNA-encoded antigens. We understand and apprec...a development programs are never "cookbook". We wi...
Biology Products: